Koh Liang-Piu, Chao Nelson J
Duke University Medical Center, Durham, North Carolina 27710, USA.
Biol Blood Marrow Transplant. 2004 Jan;10(1):1-22. doi: 10.1016/j.bbmt.2003.09.009.
Unrelated umbilical cord blood (UCB) transplantation has recently been explored in an increasing number of adult patients. The relative ease of procurement and the lower-than-anticipated risk of severe acute graft-versus-host disease has made UCB transplantation an appealing alternative to bone marrow-derived hematopoietic stem cells. The use of reduced-intensity or nonmyeloablative preparative regimens to allow engraftment of UCB broadens the scope of patients who may benefit from allogeneic immunotherapy, including elderly and medically infirm patients with no matched sibling donor. This review summarizes the available data on the use of UCB as an alternative source of hematopoietic stem cell transplantation in adult patients.
近年来,越来越多的成年患者开始探索无关供者脐血(UCB)移植。脐血采集相对容易,且严重急性移植物抗宿主病的风险低于预期,这使得脐血移植成为骨髓来源造血干细胞的一个有吸引力的替代选择。使用降低强度或非清髓性预处理方案以促进脐血植入,扩大了可能从异基因免疫治疗中获益的患者范围,包括没有匹配同胞供者且年老体弱的患者。本综述总结了关于在成年患者中使用脐血作为造血干细胞移植替代来源的现有数据。